Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial
新辅助信迪利单抗联合化疗治疗潜在可切除食管鳞状细胞癌患者(KEEP-G 03):一项开放标签、单臂、II期试验
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-005830
Chen, Xiaofeng; Xu, Xiang; Wang, Danping; Liu, Jinyuan; Sun, Jing; Lu, Mingjie; Wang, Rui; Hui, Bingqing; Li, Xiaofei; Zhou, Chenchen; Wang, Min; Qiu, Tianzhu; Cui, Shiyun; Sun, Nana; Li, Yang; Wang, Fufeng; Liu, Cuicui; Shao, Yang; Luo, Jinhua; Gu, Yanhong